Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EncisionECIA 35 Net Current Asset Value is $0.02 as of Sep. 2025. GuruFocus rates ECIA with a GF Score™ of 35/100 and a GF Value™ of $0.34 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 570 Medical Devices & Instruments companies, Encision ranks worse than 69.65% on this metric.
In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
Encision's net current asset value per share for the quarter that ended in Sep. 2025 was $0.02.
The historical rank and industry rank for Encision's Net Current Asset Value or its related term are showing as below:
ECIA'
s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 1.94 Med: 4.3 Max: 22.08
Current: 9.5
During the past 13 years, the highest Price-to-Net-Current-Asset-Value Ratio of Encision was 22.08. The lowest was 1.94. And the median was 4.30.
ECIA's Price-to-Net-Current-Asset-Value is ranked worse than 69.65% of 570
companies
in the Medical Devices & Instruments industry
Industry Median: 5.285
vs ECIA: 9.50
Encision (OTCPK:ECIA) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
Encision Net Current Asset Value Related Terms
Encision Net Current Asset Value Historical Data
* Premium members only.
The historical data trend for Encision's Net Current Asset Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ECIA vs GCTK, YBGJ, RSCF: Net Current Asset Value Comparison
For the Medical Instruments & Supplies subindustry, Encision's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Encision Price-to-Net-Current-Asset-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Encision's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where Encision's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of $0.02 mean?
Encision (ECIA) has a Net Current Asset Value of $0.02 as of Sep. 2025. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Encision and its competitors. According to the industry distribution chart, Encision ranks #397 out of 570 companies in the Medical Devices & Instruments industry, placing it in the top 69.6%.
Is Encision's Net Current Asset Value too high?
Encision's current Net Current Asset Value is $0.02. The Medical Devices & Instruments industry median Net Current Asset Value is 5.29. Encision's value of $0.02 is 99.6% below this industry median. Based on the distribution chart, Encision ranks #397 out of 570 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Encision has a GF Score™ of 35/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Encision's Net Current Asset Value compare to GCTK and YBGJ?
According to the Medical Devices & Instruments industry distribution chart, Encision ranks #397 out of 570 companies for Net Current Asset Value. This places Encision in the lower half of its industry. The industry median Net Current Asset Value is 5.29. Encision's value of $0.02 is 99.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Medical Devices & Instruments company?
The median Net Current Asset Value among Medical Devices & Instruments companies is 5.29, based on 570 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Encision's current Net Current Asset Value of $0.02 is 99.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Encision and its competitors. For the Medical Devices & Instruments industry, the median Net Current Asset Value is 5.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Encision's current Net Current Asset Value is $0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Encision stock overvalued right now?
Based on GuruFocus' analysis, Encision (ECIA) is currently considered Possible Value Trap. The stock's GF Value™ is $0.34, compared to a current price of $0.19 — trading 44.1% below its estimated fair value. The current Net Current Asset Value is $0.02 and 99.6% below the Medical Devices & Instruments industry median of 5.29. Encision's overall GF Score™ is 35/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Encision (ECIA), the current Net Current Asset Value is $0.02 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Encision (ECIA) Overvalued in 2026?
Based on GuruFocus' analysis, Encision stock appears to be undervalued.
The current stock price of $0.19 is trading 44.1% below its estimated GF Value™ of $0.34.
GuruFocus considers Encision to be Possible Value Trap.
Key valuation signals for ECIA:
Net Current Asset Value: $0.02
GF Value™: $0.34 vs. price of $0.19 (44.1% below fair value)
Industry Position: 99.6% below the Medical Devices & Instruments median (#397 of 570)
No single metric tells the full story. See the ECIA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Encision Inc is a medical device company. The company develops and markets technology that provides unprecedented outcomes and patient safety in minimally invasive surgery. The company has established and developed AEM (Active Electrode Monitoring) technology and surgical instruments which provide surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures while preventing stray electrosurgical energy that can cause complications and even death. The segments of the company are Product and Service. Product designs develops, manufactures and markets patented surgical instruments. Service performs electrical engineering activities for external entities. Maximum revenue is generated from the product segment.
35GF Score
Get the complete analysis for ECIA
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ECIA has been successfully added to your 
